SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Request Hearing before Nasdaq Hearings

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-08
Original SEC Filing: Click here


Webplus: SVA/20171108/6-K/2_EX-99.1/000.htm SEC Original: tv478960_ex99-1.htm
Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel BEIJING, November 8, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Company submitted a request for a hearing before the Nasdaq Hearings Panel (the “Panel”). As reported on November 3, 2017, the Company received a




Webplus: SVA/20171108/6-K/1/000.htm SEC Original: tv478960_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-11-08CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085

Home Page Forums

By | 2017-11-09T04:17:20+00:00 November 8th, 2017|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar